Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 2Breast 1

Conditions

Breast Neoplasms 47Triple Negative Breast Neoplasms 25Ovarian Neoplasms 8Neoplasm Metastasis 8Melanoma 8Prostatic Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Uterine Cervical Neoplasms 5Small Cell Lung Carcinoma 5Pancreatic Neoplasms 5Colorectal Neoplasms 5Carcinoma, Renal Cell 5Urinary Bladder Neoplasms 3Stomach Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Head and Neck Neoplasms 3Carcinoma, Merkel Cell 3Lung Neoplasms 2Kidney Neoplasms 2Hodgkin Disease 2Fallopian Tube Neoplasms 2Esophageal Squamous Cell Carcinoma 2Esophageal Neoplasms 2Endometrial Neoplasms 2Carcinoma, Hepatocellular 2Brain Neoplasms 2Anatomic Stage II Breast Cancer AJCC v8 2Adenocarcinoma Of Esophagus 2Uterine Neoplasms 1Thyroid Neoplasms 1

Interventions

pembrolizumab 2Trastuzumab 2Magnetic Resonance Spectroscopy 2Immunoglobulin G 2Fulvestrant 2ulixertinib 1tucatinib 1trastuzumab biosimilar HLX02 1trametinib 1seribantumab 1sapanisertib 1relatlimab 1pertuzumab 1palbociclib 1osimertinib 1omipalisib 1larotrectinib 1ipatasertib 1erdafitinib 1durvalumab 1defactinib 1dabrafenib 1copanlisib 1cemiplimab 1capivasertib 1binimetinib 1adavosertib 1X-Rays 1Sunitinib 1Specimen Handling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Uterine Neoplasms × durvalumab × Breast × Clear all
NCT02725489 2021-01-27

Pilot Study of Durvalumab and Vigil in Advanced Women's Cancers

Mary Crowley Medical Research Center

Phase 2 Completed
13 enrolled
BreastGynecologic

Breast Neoplasms, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Uterine Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡